Difficulty: Medium
Average Score: 63%
Practice
The client is on an ADP receptor blocker for the prevention of recurrent myocardial infarction. What does the nurse expect when the client develops hemorrhaging and a low platelet count?
Correct answer
C
Rationale
The correct answer is C) The client has developed thrombotic thrombocytopenia.
Thrombotic thrombocytopenia is a rare but serious side effect associated with ADP receptor blockers, specifically clopidogrel. This condition is characterized by a low platelet count and the formation of blood clots in small blood vessels throughout the body. The development of hemorrhaging and a low platelet count in a patient taking an ADP receptor blocker should raise concerns about thrombotic thrombocytopenia.
Option A is incorrect because a low platelet count is not an anticipated reaction to taking an ADP receptor blocker; it indicates a potential complication.
Option B is incorrect because taking an ADP receptor blocker with aspirin is a common practice for dual antiplatelet therapy but does not directly relate to the development of thrombotic thrombocytopenia.
Option D is incorrect because the development of thrombotic thrombocytopenia is not solely due to taking too much of the ADP receptor blocker, but rather an adverse reaction associated with the medication.
Educationally, this question emphasizes the importance of recognizing potential serious side effects of cardiovascular drugs and the need for close monitoring of patients on these medications. Nurses need to be vigilant in assessing for signs and symptoms of adverse reactions to promptly intervene and prevent further complications in patients receiving cardiovascular pharmacotherapy.
Thrombotic thrombocytopenia is a rare but serious side effect associated with ADP receptor blockers, specifically clopidogrel. This condition is characterized by a low platelet count and the formation of blood clots in small blood vessels throughout the body. The development of hemorrhaging and a low platelet count in a patient taking an ADP receptor blocker should raise concerns about thrombotic thrombocytopenia.
Option A is incorrect because a low platelet count is not an anticipated reaction to taking an ADP receptor blocker; it indicates a potential complication.
Option B is incorrect because taking an ADP receptor blocker with aspirin is a common practice for dual antiplatelet therapy but does not directly relate to the development of thrombotic thrombocytopenia.
Option D is incorrect because the development of thrombotic thrombocytopenia is not solely due to taking too much of the ADP receptor blocker, but rather an adverse reaction associated with the medication.
Educationally, this question emphasizes the importance of recognizing potential serious side effects of cardiovascular drugs and the need for close monitoring of patients on these medications. Nurses need to be vigilant in assessing for signs and symptoms of adverse reactions to promptly intervene and prevent further complications in patients receiving cardiovascular pharmacotherapy.